Autobio Diagnostics Co

Autobio Diagnostics Co Assets per Share

The Total Assets per Share of Autobio Diagnostics Co (603658.SS) as of Oct 16, 2026 is 21.30 CNY. In the previous year, Total Assets per Share was 20.58 CNY — a change of 3.49% (higher).

Assets per Share

21.30CNY

YoY

3.49%

Last updated:

Total Assets per Share of Autobio Diagnostics Co is 2025 21.30 CNY. Total Assets per Share of Autobio Diagnostics Co was 2024 20.58 CNY. It decreases by 3.49% higher compared to the previous year.

The Autobio Diagnostics Co Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
4.60 CNY
Jan 1, 2019
7.38 CNY
Jan 1, 2020
14.10 CNY
Jan 1, 2021
16.00 CNY
Jan 1, 2022
18.15 CNY
Jan 1, 2023
20.02 CNY
Jan 1, 2024
20.58 CNY
Jan 1, 2025
21.30 CNY
The Autobio Diagnostics Co Assets per Share history
YEARAssets per ShareYoY
21.30CNY+3.49%
20.58CNY+2.78%
20.02CNY+10.33%
18.15CNY+13.43%
16.00CNY+13.46%
14.10CNY+91.15%
7.38CNY+60.24%
4.60CNY+21.45%
3.79CNY+20.09%
3.16CNY+92.63%
1.64CNY+45.02%
1.13CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Autobio Diagnostics Co Stock analysis

What does Autobio Diagnostics Co do? Autobio Diagnostics Co Ltd, listed on the Shanghai Stock Exchange under ticker 603658.SS, is a healthcare company based in Zhengzhou, China. The company specializes in the research, development, manufacturing, integration, service, and distribution of in vitro diagnostic reagents and instruments. With a workforce of 5,505 employees, Autobio Diagnostics went public on September 1, 2016. Its product portfolio includes immunodiagnostic reagents such as microplate chemiluminescence diagnostic reagents, enzyme-linked immunosorbent assay (ELISA) diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The company also offers microbiology detection products, including training detection reagents, susceptibility detection reagents, and rapid detection reagents. Device products encompass microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. Autobio Diagnostics primarily serves domestic markets within China, focusing on providing diagnostic solutions for healthcare applications. The company's headquarters is located in Zhengzhou, Henan Province, and it operates within the healthcare sector, specifically in the health care industry. Its website, https://www.autobio.com.cn/, provides further information on its services and products. Autobio Diagnostics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Autobio Diagnostics Co stock

Total Assets per Share of Autobio Diagnostics Co is 21.30 CNY in 2025.

Total Assets per Share of Autobio Diagnostics Co changed from 20.58 CNY to 21.30 CNY, representing a 3.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Autobio Diagnostics Co since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Other — Autobio Diagnostics Co

Shares OutstandingSupply ChainNet Debt per ShareAssets per Share

All Key Metrics — Autobio Diagnostics Co